Insider · CIK 0001943549
Maxwell Krakowiak
Files at RVTY (REVVITY, INC.). First filing Sep 23, 2026, latest Sep 23, 2026.
In brief
Maxwell Krakowiak files SEC Form 4 as officer at RVTY (REVVITY, INC.). Since Sep 23, 2026, Maxwell Krakowiak has reported 0 open-market buys worth $0 and 1 open-market sell worth $236k, the latest filed on Sep 23, 2026.
A track record needs three past buys with six months of prices behind them; Maxwell Krakowiak has 0, so none is measured yet.
The newest scored trade: sold $236k of RVTY on Sep 21, 2026, filed Sep 23, 2026, scored 23 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $236k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RVTY: REVVITY, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | REVVITY, INC. | $236k 1,631 shares | -10% | +75% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 21, 2026 | RVTY REVVITY, INC. | 1,631 0.00% of outstanding | $236k | Sep 21, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | RVTY REVVITY, INC. | SOpen-market sale Common Stock10b5-1 | -1,631 | $144.53 | $236k | 14,781 | 20 d ago |
| Feb 17, 2026 | RVTY REVVITY, INC. | FTax withholding Common Stock | -1,457 | $96.03 | $140k | 17,314 | Feb 19, 2026 |
| Feb 17, 2026 | RVTY REVVITY, INC. | FTax withholding Common Stock | -902 | $96.03 | $87k | 16,412 | Feb 19, 2026 |
| Feb 4, 2026 | RVTY REVVITY, INC. | FTax withholding Common Stock | -708 | $101.13 | $72k | 11,509 | Feb 6, 2026 |
| Feb 4, 2026 | RVTY REVVITY, INC. | AGrant or award Common Stock | +7,262 | $0.00 | $0 | 18,771 | Feb 6, 2026 |
| Feb 4, 2026 | RVTY REVVITY, INC. | AGrant or award NQ Stock Option (right to buy)derivative | +20,771 | $0.00 | $0 | 20,771 | Feb 6, 2026 |
| Sep 15, 2025 | RVTY REVVITY, INC. | FTax withholding Common Stock | -559 | $82.87 | $46k | 12,217 | Sep 17, 2025 |
| Aug 15, 2025 | RVTY REVVITY, INC. | AGrant or award NQ Stock Option (right to buy)derivative | +44,446 | $0.00 | $0 | 44,446 | Aug 18, 2025 |
| Feb 18, 2025 | RVTY REVVITY, INC. | FTax withholding Common Stock | -50 | $112.26 | $5,613 | 12,776 | Feb 19, 2025 |
| Feb 4, 2025 | RVTY REVVITY, INC. | AGrant or award Common Stock | +5,709 | $0.00 | $0 | 12,826 | Feb 6, 2025 |
| Feb 4, 2025 | RVTY REVVITY, INC. | AGrant or award NQ Stock Option (right to buy)derivative | +15,784 | $0.00 | $0 | 15,784 | Feb 6, 2025 |
Questions about Maxwell Krakowiak
Answered from the filings on this page, as of the latest one.
Is Maxwell Krakowiak buying or selling?
In the last 12 months Maxwell Krakowiak reported 0 open-market buys worth $0 and 1 open-market sell worth $236k on SEC Form 4; the latest was sold $236k of RVTY on Sep 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Maxwell Krakowiak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Maxwell Krakowiak has 0.
Where does Maxwell Krakowiak file Form 4?
Maxwell Krakowiak has filed Form 4 at RVTY (REVVITY, INC.) as Please See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.